CoChat

Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease

Open access
Taylor, Eric N., Rimm, Eric B., Stampfer, Meir J., Curhan, Gary C. · 2011 · American Heart Journal
Cited by 102

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background Fibroblast growth factor 23 (FGF23), parathyroid hormone (PTH), and phosphorus all have been proposed as plasma biomarkers for the development of coronary heart disease (CHD) in individuals with normal renal function. Methods In a nested case-control study of men in the Health Professionals Follow-up Study free of diagnosed cardiovascular disease at blood draw, we prospectively examined associations between plasma FGF23, PTH, and phosphorus and risk of coronary heart disease (CHD). During 10 years of follow-up, 422 men developed nonfatal myocardial infarction or fatal CHD. Controls were selected in a 2:1 ratio and matched for age, date of blood collection, and smoking status. Results Mean estimated glomerular filtration rate was 86 mL/min per 1.73 m2 in cases and controls. At baseline, there were no statistically significant differences between cases and controls in plasma levels of FGF23, PTH, or phosphorus. After adjusting for matching factors, family history of myocardial infarction, body mass index, alcohol consumption, physical activity, history of diabetes mellitus and hypertension, ethnicity, region, plasma 25-hydroxyvitamin D and other factors, the odds ratios for incident CHD for participants in the highest compared to lowest quartiles were 1.03 (95% CI 0.70-1.52; P for trend 0.84) for FGF23, 1.20 (95% CI 0.82-1.76; P trend 0.99) for PTH, and 0.72 (95% CI 0.51-1.02; P trend 0.13) for phosphorus. Conclusions Plasma FGF23, PTH, and phosphorus are not associated with the development of incident CHD in men without chronic kidney disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ahj.2011.02.012

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 102

Metadata

Authors
Taylor, E. N., Rimm, E. B., Stampfer, M. J., & Curhan, G. C.
Venue
American Heart Journal
Publisher
Elsevier BV
Published
2011-05
Volume
161
Issue
5
Pages
956-962
ISSN
0002-8703 (ISSN-L)
OpenAlex
W2051186854
Cited by
102
References
7
FWCI
12.50
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. https://app.cochat.ai/papers/10.1016/j.ahj.2011.02.012
The paper
Taylor, E. N., Rimm, E. B., Stampfer, M. J., & Curhan, G. C. (2011). Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. American Heart Journal. https://doi.org/10.1016/j.ahj.2011.02.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.